Dr. Kevin A. Horvath, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1483 West Main Street, Tipp City, OH 45371 Phone: 937-667-7711 Fax: 937-667-8067 |
Kathryn Lorraine Dearing, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1483 W Main St, Tipp City, OH 45371 Phone: 937-667-7711 Fax: 937-667-8067 |
Alan Michael Wilimitis, D.O. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1483 West Main Street, Tipp City, OH 45371 Phone: 937-667-7711 Fax: 937-667-8067 |
News Archive
Researchers at the Hebrew University of Jerusalem have found a way to maintain the pain-killing qualities of morphine over an extended period of time, thus providing a solution for the problem of having to administer increasing dosages of the drug in order to retain its effectiveness.
Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. There have been several protocols available for hepatic fate specification from ES cells, however, most of the protocols currently used result in low yield or purity of functional hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has been demonstrated to facilitate the hepatic differentiation of mesenchymal stem cells. However, little is know about whether VPA could induce the hepatic differentiation of ES cells.
MyClyns, the new non-alcohol germ protection spray, is now available to consumers over the counter throughout Greater Cleveland, one of two cities in the nation chosen as initial test market cities prior to a nationwide product launch.
When a newly diagnosed cancer patient is considering treatment options, proton therapy might not be the first course that comes to mind. Yet over the past two decades proton therapy has continued to evolve as a viable alternative to chemotherapy and a less-invasive procedure than radiation or surgery, so much so that proton therapy is now considered the preferred course of treatment for many doctors and patients in the fight against cancer.
After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.
› Verified 8 days ago